Guidelines of the International Headache Society for controlled clinical trials in idiopathic intracranial hypertension

Mollan, S.P.; Fraser, C.L.; Digre, K.B.; Diener, H.C.; Lipton, R.B.; Juhler, M.; ... ; Jensen, R.H. (2023)

Article / Letter to editor

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

• Guidelines
• Randomised control trial
• Pseudotumor cerebri
• papilloedema
• raised intracranial pressure
• headache
• vision
• drug
• lumbar puncture
• Idiopathic intracranial hypertension

• All authors: Mollan, S.P.; Fraser, C.L.; Digre, K.B.; Diener, H.C.; Lipton, R.B.; Juhler, M.; Miller, N.R.; Pozo-Rosich, P.; Togha, M.; Brock, K.; Dinkin, M.J.; Chan, C.K.M.; Tassorelli, C.; Sinclair, A.J.; Terwindt, G.M.; Jensen, R.H.
• Date: 2023-08-01
• Journal: Cephalalgia
• Volume: 43
• Issue: 8
• DOI: doi:10.1177/03331024231197118
• Link: https://journals.sagepub.com/doi/10.1177/03331024231197118